The German Breast Group conducts research into breast cancer, developing and implementing its own study concepts.
With the help of additional scientific research projects, we strive to gain further insights into this disease.
A translational research project aiming to identify predictive markers for response to bevacizumab treatment in HER2-negative breast cancer from GeparQuinto study has been published in Clinical Cancer Research.
We are pleased to inform you that the surgical results of the randomized BrighTNess trial have been published in JAMA Surgery.
We are delighted to inform you that the long-term follow-up results of the randomized IBIS-II trial have been published in Lancet.
Results of a protocol-predefined secondary analysis from PANTHER trial have been published in Cancer.
A translational study evaluating the role of tumor immunogenicity in patients from GeparTrio trial has been published in Breast Cancer Research.
Every month, we present an interesting paper.
We are delighted to inform you that our analysis on the utility of the CPS + EG score in triple-negative breast cancer patients has been published in European Journal of Cancer